||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Consort Med. Share Discussion Threads
Showing 101 to 120 of 125 messages
Surely if you are a big exporter then more pounds for your Euro at present. Even if we end up out of the single Market and get hit with say a 5% import tax into the EU then the current 10% drop in the £ value would more than cover it. At present and for the next 2-3 years it is a windfall, net of course of any hike import raw material rises.|
|Martini, as per Aesop's fable the tortoise can and does beat the hare.
I did not make the AGM and would be interested to hear from anyone who did- I have quite a lot in this company-at least by my standards- and one reason for me not going was that I get(or at least I like to think I get) a good feel from the 2 analysts webcasts they have pa and the analysts ask on the whole good questions.
I was very interested in how relaxed they are ref Brexit given their heavy European involvement.|
|The Market likes it. What am I doing in this "sensible" share?|
|Just listened to the webcast of the prelims. For those who will be listening need to be patient as they have about 10 minutes of music at the start.
Upbeat presentation and good q and a. interesting this was held a week before the referendum and despite 2/3rds of sales in Europe ex UK no one asked about effects of referendum.
An obvious question if I make the AGM
Another thing I did not get a clear handle on is how much inventory risk they have but was pleased to see year end inventories were £30m against H2 sales of £276m so quick turnover.
A good deal of discussion on dev 610 and fact that built a factory bigger than the Nicoventures one for that but I was not sure who has the risk if the orders are not there…especially as they mentioned that given high fixed costs they have a high operating leverage.
Good to see positive comment on Voke.
Continue to be comfortable with my holding and do not see myself as buying or selling.|
|Thanks for that aim_master
Need to have a good look at the figures; I do see that 60%+ sales are in Europe so I went to see if they had a Risks section in these prelims to see what if anything they say on the referendum but they did not have this section(nothing unusual about that) so will need to wait till the annual report.|
|What caught my eye from this morning's announcement is that CSRT has 2k employees-never appreciated it was that big|
|Consort Medical plc (CSRT) PT Raised to GBX 1,150 at Investec
|Looking good going into the last day of 2015.|
|E-cigarettes will be prescribed on the NHS for the first time in the New Year but ministers are said to have tried to keep the move quiet over fears that GPs would be overrun by people demanding them.
Doctors will soon be able to hand out the device to smokers who want to quit, a move that will reportedly cost the NHS in the region of £20 per kit and £10 a week for each patient's cartridges.
But public health minister Jane Ellison is said to have hoped that the government could keep the news under wraps until the e-cigarettes are available via prescription in 2016.
According to Nigel Nelson of the Sunday People, a Whitehall source said: 'We didn't want to make a song and dance about it because GPs would be overrun by people demanding it.
'But this is something we've been pushing for.'
Ms Ellison had to reveal details of the e-cigarette plan after being asked a direct question by Labour MP Steve McCabe.
She told him that the Government believed 'vaping' was 'significantly less harmful than smoking' and added that medicinal license applications were 'encouraged'.
It followed last month's decision by the Medicines and Healthcare products Regulatory Agency to license British American Tobacco's e-Voke.
Read more: http://www.dailymail.co.uk/health/article-3348012/First-e-cigarettes-prescribed-NHS-New-Year.html#ixzz3tcXZDAg3
Follow us: @MailOnline on Twitter | DailyMail on Facebook|
|Gone through the interims.
All rather complicated given trying to work out the impact of the Aesica acquisition and the fact that they did not have a results presentation webcast-I find these very useful. Overall I have the sense that we could have done with more info.
Broadly speaking the kind of results we have come to expect- solid steady progress.
Liked the cash flow statement with net cash from operating activities at £16 m well in excess of the £11m combined of investment and equity dividend outflows. Also the organic sales growth of both Bespak and Aesica.
I was reminded of the importance of Europe to Aesica-ie European sales have gone up from £28m to £85m.Also Aesica had issues with profitability-its operating profit before special items was only £5m compared to Bespak's £11.5m and Aiseca's total assets at £286m dwarfed those of Bespak at £110m.
Also Goodwill represents more than 25% of total assets and will be V interesting to read the footnotes on valuation of goodwill in the annual report.
I am not planning to either buy or sell in the immediate future and my take is that for the next few months the share price will be on the 940/1020 range.
PS Nicoventures seems to have gone V quiet
PPS I see that following the results Investec have a buy with a tp at 1033 and Brewin Dolphin a hold-both of which to me are in the zone. I see that revenue projections for this FY are unchanged at £284.95m and earnings also unchanged at 50.85p
PPPS I see they are talking about confidence in meeting board's expectations for the Full year and would be good if we knew what it is.|
|Had a look at the accounts and listened to the webcast.
Putting on one side the increase in the IAS19 Pension Deficit and the £17m special charge from continuing operations, a lot of good news. Glenn emphasized in the webcast that he integration going on plan; bpk put three projects into their development programme where normally they would guide for one pa and debt s lower than forecast.
Given the increase in shares probably not realistic to expect an increase in the dividend, and management said they wanted to decrease debt.
I continue to feel very comfortable with my holding here and am not planning to buy or sell|
|Interested to read the announcement today. The way I read their comments today and indeed previously is that the plant for this has been built for 6 months and it seems unoccupied except for testing so quite a lot invested.
Note that in the Annual/Interim Report they said to expect CE mark in H1 2015 . No emphasis on this product mentioned in the interims so perhaps do not see this as a key product, but also note they have invested £6m which for CSRT is a lot ie total investment in property plant and equipment was £7m in first half of this year. Cannot find any figure for total investment anticipated in Atlas and also today seems to be the first time we have been given a timeline.|
|Up 8% on today's results - nice!|
|Broker Views on CSRT........
Consort Medical PLC
Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p)
06-11-14 None 17.94 41.28 18.11 18.91 43.21 18.11
Peel Hunt LLP
06-11-14 BUY 22.62 37.99 19.02 33.78 47.65 19.96
N+1 Singer [D]
06-11-14 HOLD 22.37 35.90 17.90 32.54 45.40 17.90
06-11-14 BUY 22.80 45.01 18.11 33.30 53.63 19.50
31-10-14 BUY 18.40 46.18 18.11 20.00 49.68 18.11
31-10-14 HOLD 22.00 39.80 20.70 32.10 51.40 20.70
Canaccord Genuity Ltd
09-10-14 BUY 22.26 37.40 14.34 33.34 46.56 18.11
Numis Securities Ltd
01-10-14 HOLD 18.60 45.48 18.11 20.20 49.33 18.11
04-09-14 BUY 18.30 52.14 20.70 19.60 55.83 20.70|
|CSRT CONSORT MEDICAL,lovely tech set up here, results in about a month. Investech set 986p target Canaccord 996p target.
100% of IG client accounts with open positions in this market expect the price to rise.
0% of IG client accounts with open positions in this market expect the price to fall.|
|Intriguing deal announced today
I am taking up all my rights|
|i traded CSRT mid year, bought and then sold when the share price hovered early july. The recent drop may be a buying opportunity and i'm currently researching latest news too. Will advise if i buy.
Been doing very little at all lately, playing the waiting game but being mostly cash for most of the year the recent falls across the markets may be presenting some opportunities.